Caterpillar (NYSE:CAT): The U.S. non-residential real estate market is improving with strong construction activity

/ / Industrials /

CEO of Caterpillar (NYSE:CAT): The U.S. non-residential real estate market is improving and construction activity is strong; The Company’s sales and profit position is expected to improve year-on-year. There are still some practical challenges in the supply chain; Chip supply has yet to return to pre-pandemic levels.

Caterpillar (NYSE:CAT): The U.S. non-residential real estate market is improving with strong construction activity Read Post »

Meta Platforms (NASDAQ:META): Expect to cut around 10,000 jobs and suspend hiring for about 5,000 positions

/ / Technology /

Meta Platforms (NASDAQ:META): Expect to cut around 10,000 jobs and suspend hiring for about 5,000 positions. Plans to reduce the number of employees in the technical group are expected to be announced in late April. The size of the hiring team will be further reduced, and the layoffs of the commercial team are expected to be announced at the end of May, focusing on optimizing the proportion of engineers.

Meta Platforms (NASDAQ:META): Expect to cut around 10,000 jobs and suspend hiring for about 5,000 positions Read Post »

Pfizer (NYSE:PFE) to acquire Seagen (NASDAQ:SGEN) for $43 billion

/ / Health Care / ,

Pfizer Inc (NYSE:PFE) said Monday it agreed to buy biotech company Seagen Inc (NASDAQ:SGEN) for $43 billion to bolster its cancer treatment program. The New York-based drugmaker said it would pay $229 a share in cash, a nearly 33 percent premium to Seagen’s closing price of $172.61 on Friday. Seagen is headquartered in Bothel, Washington. Pfizer said it expects to fund most of the acquisition through $31 billion of new long-term debt, with the rest coming from short-term financing and cash on hand. Pfizer said it expects the deal with Seagen to have a neutral to slightly higher impact on adjusted earnings per share in the third to fourth full year after closing, and said it expects to achieve cost efficiencies of nearly $1 billion in the third full year.

Pfizer (NYSE:PFE) to acquire Seagen (NASDAQ:SGEN) for $43 billion Read Post »

Buzzfeed (NASDAQ:BZFD) Q4 2022 revenue of $134.6 million, down 8% year-over-year

/ / Technology

Buzzfeed (NASDAQ:BZFD)  reported a Q4 diluted loss  of $0.75 per share, Analysts polled by Capital IQ expected a loss of $0.03. Revenue for the quarter that ended Dec. 31 was $134.6 million, Analysts surveyed by Capital IQ expected $131.3 million. The company expects Q1 2023 revenue to be $61 million to $67 million. Analysts polled by Capital IQ expect $83.6 million.

Buzzfeed (NASDAQ:BZFD) Q4 2022 revenue of $134.6 million, down 8% year-over-year Read Post »

United Airlines(NASDAQ:UAL) expects Q1 2023 operating revenue up approximately 51% versus Q1 2022

/ / Consumer Discretionary /

now expects first quarter 2023 total operating revenue to be up approximately 51% versus first quarter 2022, higher than the Company’s initial approximately 50% expectation provided in January 2023. the Company now expects an adjusted diluted loss per share of between $0.60 and $1.00 in the first quarter 2023. While all months of 2023 are expected to produce unit revenue significantly above the corresponding months in 2019. the Company now expects a first quarter 2023 average fuel price per gallon of between $3.31 and $3.41. The Company continues to expect a full year 2023 adjusted pre-tax margin of approximately 9% and full year adjusted diluted earnings per share1 of $10 to $12.

United Airlines(NASDAQ:UAL) expects Q1 2023 operating revenue up approximately 51% versus Q1 2022 Read Post »

GitLab(NASDAQ:GTLB) Q4 2023 revenue of $122.9 million,up 58% year-over-year

/ / Technology /

March 13, 2023 — All-Remote – GitLab Inc. (NASDAQ: GTLB), The DevSecOps Platform, today reported financial results for its fourth quarter and full fiscal year of 2023, ended January 31, 2023. GitLab Inc. (NASDAQ: GTLB) reported a fiscal Q4 non-GAAP net loss of $0.03 per share,  Analysts polled by Capital IQ forecast a per-share loss of $0.14. Revenue for the quarter ended Jan. 31 was $122.9 million,  Analysts polled by Capital IQ projected $119.6 million. The company said it expects a fiscal Q1 non-GAAP loss of $0.15 to $0.14 per share on revenue of $117 million to $118 million. Analysts polled by Capital IQ are looking for a loss of $0.16 per share and revenue of $126.4 million. GitLab estimates a non-GAAP loss of $0.29 to $0.24 per share and revenue of $529 million to $533 million for fiscal 2024. Analysts polled by Capital IQ are expecting a loss of $0.52 per

GitLab(NASDAQ:GTLB) Q4 2023 revenue of $122.9 million,up 58% year-over-year Read Post »

DA Davidson: Pacwest Bancorp (NASDAQ:PACW) presents a buying opportunity with its price target cut to $29

/ / Financials / ,

D.A. Davidson analysts Gary Tenner and Clark Wright said the Silicon Valley bank bankruptcy is a buying opportunity for PacWest (NASDAQ:PACW) stock. “We think last week’s sell-off provides a more attractive buying point for investors, especially after the Fed’s announcement on Sunday of the launch of the Bank’s Term Financing Program (BTFP),” the analyst said. “Analysts upgraded the stock to Buy and lowered its price target to $29.

DA Davidson: Pacwest Bancorp (NASDAQ:PACW) presents a buying opportunity with its price target cut to $29 Read Post »

Pfizer (NYSE:PFE) intends to acquire Seagen (NASDAQ:SGEN) for $229 per share in cash

/ / Health Care / ,

Pfizer (NYSE:PFE) will reportedly acquire Seagen (NASDAQ:SGEN) for $43 billion in total enterprise value for $229 per share in cash. Seagen’s risk-adjusted revenue contribution is expected to exceed $10 billion in 2030. Pfizer expects to finance the transaction primarily through a new borrowing of $31 billion of long-term debt, with the remainder coming from short-term financing and cash on hand.

Pfizer (NYSE:PFE) intends to acquire Seagen (NASDAQ:SGEN) for $229 per share in cash Read Post »

Scroll to Top